PAM
AMED

Panagora Asset Management’s Amedisys AMED Stock Holding History

Panagora Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-450
Closed -$110K – 1727
2021
Q2 		$110K Hold
450
– – ﹤0.01% 1868
2021
Q1 		$119K Sell
450
-2,948
-87% -$831K ﹤0.01% 1911
2020
Q4 		$997K Sell
3,398
-751
-18% -$193K 0.01% 966
2020
Q3 		$981K Sell
4,149
-13,005
-76% -$2.96M 0.01% 905
2020
Q2 		$3.41M Sell
17,154
-4,915
-22% -$917K 0.02% 509
2020
Q1 		$4.05M Sell
22,069
-4,592
-17% -$817K 0.03% 401
2019
Q4 		$4.45M Sell
26,661
-1,299
-5% -$193K 0.02% 518
2019
Q3 		$3.66M Sell
27,960
-2,272
-8% -$296K 0.02% 543
2019
Q2 		$3.67M Buy
30,232
+10,506
+53% +$1.25M 0.02% 595
2019
Q1 		$2.43M Sell
19,726
-117
-0.6% -$14.7K 0.01% 759
2018
Q4 		$2.32M Buy
+19,843
New +$2.34M 0.01% 727
2017
Q2 		– Sell
-4,927
Closed -$252K – 2584
2017
Q1 		$252K Sell
4,927
-88,909
-95% -$4.24M ﹤0.01% 1582
2016
Q4 		$4M Sell
93,836
-69,732
-43% -$2.97M 0.02% 629
2016
Q3 		$7.76M Buy
163,568
+40,376
+33% +$2.01M 0.04% 427
2016
Q2 		$6.22M Sell
123,192
-41,080
-25% -$2.07M 0.03% 488
2016
Q1 		$7.94M Buy
164,272
+99,952
+155% +$3.86M 0.04% 428
2015
Q4 		$2.53M Buy
64,320
+60,872
+1,765% +$2.43M 0.01% 736
2015
Q3 		$131K Buy
3,448
+1,870
+119% +$78.9K ﹤0.01% 1736
2015
Q2 		$63K Sell
1,578
-7,807
-83% -$243K ﹤0.01% 2083
2015
Q1 		$251K Sell
9,385
-3,526
-27% -$99.5K ﹤0.01% 1582
2014
Q4 		$379K Sell
12,911
-24,067
-65% -$594K ﹤0.01% 1387
2014
Q3 		$746K Buy
36,978
+8,029
+28% +$155K ﹤0.01% 1170
2014
Q2 		$485K Buy
28,949
+20,732
+252% +$294K ﹤0.01% 1389
2014
Q1 		$122K Buy
+8,217
New +$126K ﹤0.01% 1879

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Panagora Asset Management's AMED Position: Q3 2021 in Review

Panagora Asset Management sold out of Amedisys (AMED) in Q3 2021, closing a stake of 450 shares — an estimated $110K sold.

Panagora Asset Management first reported a position in AMED in Q1 2014 and held it in 24 quarters. The position peaked at $7.94M in Q1 2016. 351 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Panagora Asset Management reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • Panagora Asset Management sold 450 Amedisys shares in Q3 2021, an estimated $110K.
  • Panagora Asset Management first reported a position in Amedisys in Q1 2014 and held it in 24 quarters.
  • Panagora Asset Management's Amedisys position peaked at $7.94M in Q1 2016.
  • 351 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.